The effects of bradykinin are mediated through its interaction with specific cell surface receptors, primarily the B1 and B2 receptors. These receptors are G-protein-coupled receptors (GPCRs) that initiate various intracellular signaling pathways upon activation. The B2 receptor is constitutively expressed in many tissues, while the B1 receptor is usually induced during inflammation.
